Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Supply Chain
Awards
Outsourcing Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Supply Chain
Awards
Outsourcing Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Kerendia
Pharma
Bayer tees up Kerendia for major CKD label expansion
With a new phase 3 win for its ascendant Kerendia, Bayer is one step closer to pushing the med into a much broader chronic kidney disease population.
Fraiser Kansteiner
Mar 16, 2026 9:46am
Bayer's pharma division sees one more year of declining sales
Mar 4, 2026 11:35am
Bayer stays positive on newer meds as pharma sales stagnate
Nov 12, 2025 11:46am
Bayer has laid off over 12K during Bill Anderson's tenure as CEO
Aug 6, 2025 11:37am
FDA broadens label for Bayer's Kerendia to treat heart failure
Jul 14, 2025 8:39am
FDA approves use of Bayer's Nubeqa in all patients with mCSPC
Jun 4, 2025 11:38am
